• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

New insights into the role of the aryl hydrocarbon receptor in the function of CD11c+ cells during respiratory viral infection

tetano

Editor, Senior Moderator
Eur J Immunol. 2014 Feb 12. doi: 10.1002/eji.201343980. [Epub ahead of print]
New insights into the role of the aryl hydrocarbon receptor in the function of CD11c+ cells during respiratory viral infection.
Jin GB, Winans B, Martin KC, Lawrence BP.
Author information
Abstract

The aryl hydrocarbon receptor (AHR) has garnered considerable attention as a modulator of CD4 lineage development and function. It also regulates antiviral CD8+ T-cell responses, but via indirect mechanisms that have yet to be determined. Here, we show that during acute influenza virus infection, AHR activation skews dendritic cell (DC) subsets in the lung-draining lymph nodes, such that there are fewer conventional CD103+ DCs and CD11b+ DCs. Sorting DC subsets reveals AHR activation reduces immunostimulatory function of CD103+ DCs in the MLNs, and decreases their frequency in the lung. DNA binding domain (DBD) Ahr mutants demonstrate that alterations in DC subsets require the ligand-activated AHR to contain its inherent DBD. To evaluate the intrinsic role of AHR in DCs, conditional knockouts were created using Cre-LoxP technology, which reveal that AHR in CD11c+ cells plays a key role in controlling the acquisition of effector CD8+ T cells in the infected lung. However, AHR within other leukocyte lineages contributes to diminished na?ve CD8+ T-cell activation in the draining lymphoid nodes. These findings indicate DCs are among direct targets of AHR ligands in vivo, and AHR signaling modifies host responses to a common respiratory pathogen by affecting the complex interplay of multiple cell types. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved.
KEYWORDS:

Antiviral immunity, CD8+ T cells, Dendritic cells (DCs), Influenza A virus

PMID:
24519489
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24519489
 
Back
Top Bottom